Back to search

University of British Columbia

Identifying predictive gene expression signatures of sepsis severity

Abstract

dc:description

Sepsis is a common and very heterogenous syndrome defined as the life-threatening organ dysfunction caused by an aberrant host response to infection. In the earliest stages, sepsis diagnoses are often missed due to non-specific symptomatology resulting in a rapid progression to severe sepsis. Gene expression signatures that measure host immune responses have been shown to provide more sensitive prognostic tools than existing clinical criteria, permitting early prediction of high-risk patients. We recruited, from six global cohorts, 266 suspected sepsis patients in the emergency room and 82 suspected pulmonary sepsis patients in the intensive care unit with varying disease severity, and 44 healthy controls. Most recently, I analyzed 135 patients with Covid-19 disease that showed immune responses overlapping with sepsis. From this, I identified candidate gene expression signatures reflecting endotypes and severity markers, using the transcriptomics method, RNA-Seq, and statistical and computational methods. I determined that early sepsis patients could be stratified into five endotypes defined by distinct pathobiological mechanisms, including unique gene expression differences and accurate, predictive gene expression pairs. Two of the five endotypes were associated with a higher tendency towards severe sepsis and mortality, two demonstrated much lower severity, and one was relatively benign. Diverse molecular responses were also observed independently of endotypes; thus, concomitant cross-cutting severity signatures that directly predicted sepsis-induced organ dysfunction and mortality were identified, in addition to dysregulated and co-expressed module genes. The endotype signatures were often consistent with cellular shifts in neutrophil numbers and function, whereas dysregulated molecular responses like cellular reprogramming and hyperinflammation reflected prognoses. These signatures were assessed in other conditions (e.g., pancreatitis, appendicitis, myocardial infarction), which indicated the signatures captured mechanisms specific to early sepsis/sepsis. A compendium of dysregulated genes and signatures in sepsis was curated from the literature, confirming that these signatures involved wellcharacterized genes. This study demonstrated that signatures relevant to the development of life-threatening sepsis can be observed as early as first entry into the ER. These signatures will enable the development of diagnostics and targeted therapeutics, and importantly, when used early in the sepsis disease course, could prevent rapid patient deterioration, mortality, and poor long-term outcomes.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Baghela, Arjun
Contributors dc:contributor
  • Hancock, R. E. W. (Robert E. W.)
  • Cohen Freue, Gabriela V.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/81219

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Baghela, Arjun. Identifying predictive gene expression signatures of sepsis severity. doctoral thesis, University of British Columbia, 2022. http://hdl.handle.net/2429/81219